Macitentan: entry-into-humans study with a new endothelin receptor antagonist

por Sidharta, Patricia N., van Giersbergen, Paul L. M., Halabi, Atef, Dingemanse, Jasper
Publicado 2011

First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials

por Moehrle, Joerg J, Duparc, Stephan, Siethoff, Christoph, Giersbergen, Paul L M, Craft, J Carl, Arbe-Barnes, Sarah, Charman, Susan A, Gutierrez, Maria, Wittlin, Sergio, Vennerstrom, Jonathan L
Publicado 2013